论文部分内容阅读
目的探讨对高血压脑出血患者使用尼莫地平的临床疗效。方法选取我院近年收治的高血压脑出血患者共66例,随机分为对照组及观察组。对照组采用常规模式治疗,观察组另加用尼莫地平药物。对比两组患者血肿量、水肿量改善情况以及治疗总有效率差异性。结果观察组在治疗14天时在血肿量、水肿量改善程度上明显更高;治疗有效率方面,对照组治疗总有效率为84.85%,观察组则达到96.97%,各项对比差异有统计学意义(P<0.05)。结论对高血压脑出血患者加用尼莫地平可有效改善患者血肿、水肿情况,提升治疗有效性。
Objective To investigate the clinical efficacy of nimodipine in patients with hypertensive intracerebral hemorrhage. Methods Sixty-six patients with hypertensive intracerebral hemorrhage admitted in our hospital in recent years were randomly divided into control group and observation group. The control group was treated with conventional mode, the observation group plus nimodipine drugs. Comparison of two groups of patients with hematoma volume, edema volume improvement and the total effective rate of treatment differences. Results The observation group was significantly improved in the amount of hematoma and edema on the 14th day after treatment. The effective rate of treatment was 84.85% in the control group and 96.97% in the observation group, and the difference was statistically significant (P <0.05). Conclusion The addition of nimodipine to patients with hypertensive intracerebral hemorrhage can effectively improve the hematoma and edema, and improve the therapeutic efficacy.